Express News | CNS Pharmaceuticala Shares Are Trading Lower After the Company Announced the Pricing of a Registered Direct Offering and Concurrent Private Placement of 568,000 Shares at $2.45 per Share

BenzingaJun 26 11:02 ET

CNS Pharmaceuticals Stock Falls on Pricing of Direct Offering

Seeking AlphaJun 26 08:14 ET

CNS Pharmaceuticals Announces Pricing of Registered Direct Offering and Concurrent Private Placement of 568K Shares At $2.45/Share

The closing of the Offering is expected to occur on or about June 27, 2024, subject to the satisfaction of customary closing conditions.

BenzingaJun 26 08:04 ET

Trending Stocks Today: Regis Shoots up 259.17%

June 25th - US stocks trending in regular trading hours.Gainers: $Regis(RGS.US)$ surges 259.17% to $18.21 with a turnover of $554.51 million. $Volcon(VLCN.US)$ soars 145.35% to $9.52 with a turnover o

Moomoo NewsJun 25 14:00 ET

12 Health Care Stocks Moving In Thursday's Pre-Market Session

GainersTempest Therapeutics (NASDAQ:TPST) shares rose 32.8% to $3.79 during Thursday's pre-market session. The company's market cap stands at $84.0 million. Neurogene (NASDAQ:NGNE) shares rose 31.92%

BenzingaJun 20 08:05 ET

How Is The Market Feeling About CNS Pharma?

CNS Pharma's (NYSE:CNSP) short percent of float has risen 9289.47% since its last report. The company recently reported that it has 199 thousand shares sold short, which is 53.52% of all regular share

BenzingaJun 18 16:45 ET